Drug Shortage Report for GENTAMICIN(E)
| Report ID | 185563 |
| Drug Identification Number | 02082152 |
| Brand name | GENTAMICIN(E) |
| Common or Proper name | GENTAMICIN(E) |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | GENTAMICIN |
| Strength(s) | 1.6MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 80mg/50mL (JB0852P) |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-02-24 |
| Actual start date | 2023-02-24 |
| Estimated end date | 2023-03-27 |
| Actual end date | 2023-03-27 |
| Shortage status | Resolved |
| Updated date | 2023-03-28 |
| Company comments | Baxter product Gentamicin Sulfate Injection in 0.9% Sodium Chloride Injection 1 mg / mL (100 mg / 100 mL) (JB0863) is available as a substitute if aligned with clinical practice. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-03-28 | English | Compare |
| v7 | 2023-03-27 | French | Compare |
| v6 | 2023-03-27 | English | Compare |
| v5 | 2023-03-27 | French | Compare |
| v4 | 2023-03-27 | English | Compare |
| v3 | 2023-02-25 | English | Compare |
| v2 | 2023-02-24 | French | Compare |
| v1 | 2023-02-24 | English | Compare |
Showing 1 to 8 of 8